- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT01586039
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep
Investigating the Effects of Evening Light Exposure on Melatonin Suppression, Alertness and Nocturnal Sleep.
The timing and quality of sleep is governed by environmental and physiologic factors. Environmental factors, especially ambient lighting can impact the circadian system and alter the timing and structure of sleep. Light exposure can also acutely alter neural activation state and impair sleep. These effects all demonstrate marked sensitivity to short-wavelength blue light with maximal sensitivity in the 460-480 nm range. The alerting effects of blue light in the evening persist for at least 3-4 hours after the lights are turned off, and can disturb subsequent sleep. Avoiding these deleterious effects of light exposure prior to sleep on subsequent sleep would be beneficial to sleep quality and potentially health.
The investigators will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light. The investigators will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL). In a within-subject design, the investigators will test the hypotheses that exposure to a blue-depleted LED as compared to a CFL exposure at (1) 90 lux or (2) 50 lux will cause significantly:
- Less melatonin suppression between melatonin onset and bedtime;
- Less subjective and objective alerting responses before bedtime;
- Less disruption of nocturnal sleep structure and quality.
Studieöversikt
Status
Betingelser
Intervention / Behandling
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Massachusetts
-
Boston, Massachusetts, Förenta staterna, 02115
- Brigham and Women's Hospital
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion Criteria:
(i) Aged between 18-30 years to reduce the confounding effects of lens aging on the transmission of light to the retina;
(ii) Non-smoking for at least 6 months;
(iii) Healthy (no medical, psychiatric or sleep disorders);
(iv) No clinically significant deviations from normal in medical history, vital signs, physical examination, blood chemistry and hematology, urine chemistry and ECG;
(v) Women of childbearing potential must agree to use an acceptable method of birth control, and must have a negative urine pregnancy test;
(vi) Body mass index of > 18 or < 30 kg/m2;
(vii) No drugs or medication likely to affect sleep or alertness, as determined by the investigators;
(viii) Habitual caffeine consumption < 300mg per day on average;
(ix) Habitual alcohol consumption < 10 alcoholic units per week on average.
Exclusion Criteria:
(i) History of alcohol or substance abuse;
(ii) Positive result on drugs of abuse screening;
(iii) Current or past history of sleep disorders, including but not limited to obstructive sleep apnea, or any significant sleep complaint;
(iv) Psychiatric disorder;
(v) Recent acute or chronic medical disorder, including but not limited to hepatic impairment and severe chronic obstructive pulmonary disease;
(vi) Visual disorder, including but not limited to color blindness, or family history of glaucoma;
(vii) History of intolerance or hypersensitivity to melatonin or melatonin agonists;
(viii) Pregnancy or lactation;
(ix) Shift work;
(x) Transmeridian travel (2 or more time zones) in past 2 months;
(xi) Any other reason as determined by the Principal Investigator.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Grundläggande vetenskap
- Tilldelning: Randomiserad
- Interventionsmodell: Faktoriell uppgift
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Aktiv komparator: Compact Fluorescent Light 90 lux
90 lux exposure of a commercially available Compact Fluorescent Light (CFL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Experimentell: Blue-depleted LED light 90 lux
90 lux exposure of a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Aktiv komparator: Compact Fluorescent Light 50 lux
50 lux exposure of a commercially available Compact Fluorescent Light (CFL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Experimentell: Blue-depleted LED light 50 lux
50 lux exposure of a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
We will compare the effects of two light sources, equated for visual stimulus (lux), on multiple non-visual responses to light including melatonin suppression before bedtime.
We will compare a 90 lux exposure of a commercially available Compact Fluorescent Light (CFL) with a novel LED white light source that is depleted in the short-wavelength visible range (Biological Illumination LCC, FL).
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Melatonin Suppression
Tidsram: 6-h constant posture interval of the light exposure
|
Melatonin suppression is measured as the percentage of melatonin AUC relative to the AUC measured in dim light on the previous day.
AUC was calculated during the 6 h of light exposure and the corresponding 6-h interval 24 hours earlier.
Higher values indicate more light-induced melatonin suppression.
|
6-h constant posture interval of the light exposure
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Sleep Structure
Tidsram: 8-h time in bed immediately following CFL/LED light exposure.
|
Sleep efficiency assessed by polysomnography.
Sleep efficiency refers to the percentage of time a person sleeps, in relation to the amount of time a person spends in bed trying to sleep.
The percentage is calculated by dividing the Total Sleep Time by the Total Time in Bed.
|
8-h time in bed immediately following CFL/LED light exposure.
|
Sleep Quality
Tidsram: First morning after 8-h time in bed immediately following CFL/LED light exposure.
|
Self-reported sleep quality was assessed using a post sleep questionnaire.
Score on subjective scale range 1-7, higher scores indicate higher sleep quality.
|
First morning after 8-h time in bed immediately following CFL/LED light exposure.
|
Subjective Alerting Response
Tidsram: 6-h constant posture interval of the light exposure.
|
Self-reported sleepiness measured during the light exposure using the Karolinska Sleepiness Scale (KSS).
Range of scores 1-9, higher score indicate higher subjective sleepiness.
Measures were taken hourly throughout the 6-hour constant posture interval of the light exposure and then averaged to calculate a single value per participant.
|
6-h constant posture interval of the light exposure.
|
Objective Alerting Response
Tidsram: 6-h constant posture interval of the light exposure
|
Mean reaction time assessed using the 10-minute psychomotor vigilance test.
Higher numbers indicate slower reaction times indicating less alertness.
Measures were taken hourly throughout the 6-hour constant posture interval of the light exposure and then averaged to calculate a single value per participant.
|
6-h constant posture interval of the light exposure
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Steven W Lockley, Ph.D., Brigham and Women's Hospital; Harvard Medical School
Studieavstämningsdatum
Studera stora datum
Studiestart
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Uppskatta)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- 2011-P-002834
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
produkt tillverkad i och exporterad från U.S.A.
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Non-visual Photoreception
-
Benha UniversityAvslutad
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityRekryteringVisual Health of Virtual RealityKina
-
University of Illinois at Urbana-ChampaignAvslutadKognitiv förändring | Bearbetning, Visual SpatialFörenta staterna
-
New York City Health and Hospitals CorporationAvslutadGlaukom | Näthinnesjukdom | Visual Pathway DisorderFörenta staterna
-
Neuro-Eye Diagnostic Systems, LLCNeuro-ophthalmology of Texas PLLCAnmälan via inbjudanMakulasjukdom | Visual Pathway Disorder | SynnervssjukdomFörenta staterna
-
University of Illinois at Urbana-ChampaignAvslutadKognitiv förändring | Fungerande minne | Hämning (psykologi) | Bearbetning, Visual SpatialFörenta staterna
-
University of ZurichUSZ FoundationAktiv, inte rekryterande
-
Korea University Anam HospitalKorea UniversityAvslutadSmärtmätning | Visual Analog Pain Scale
-
Alanya Alaaddin Keykubat UniversityAvslutadSterilisering, Tubal | Visual Analog Pain Scale
Kliniska prövningar på Visible light
-
George Washington UniversityAktiv, inte rekryterandeAmningFörenta staterna
-
Massachusetts General HospitalAmerican Cancer Society, Inc.Avslutad
-
University of British ColumbiaHeart and Stroke Foundation of Canada; Public Health Agency of Canada (PHAC) och andra samarbetspartnersAvslutadFetma, PediatriskKanada
-
Calhoun Vision, Inc.AvslutadGrå starrFörenta staterna
-
Dent Neuroscience Research CenterGenentech, Inc., a subsidiary of F. Hoffman-La Roche AG; Monogram Biosciences...Har inte rekryterat ännuMultipel skleros | Återkommande förlöpande multipel skleros
-
Maimonides Medical CenterFoundation for Prader-Willi ResearchRekryteringKroppsvikt | Hyperfagi | Prader-Willis syndrom | Humör | Beteende | Överdriven sömnighet på dagarnaFörenta staterna
-
Stanford UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...Rekrytering
-
United States Air Force Research LaboratoryOhio State University; Uniformed Services University of the Health Sciences och andra samarbetspartnersRekryteringFysiologiskt välbefinnandeFörenta staterna
-
M.D. Anderson Cancer CenterAvslutadAvancerad cancerFörenta staterna
-
Siperstein DermatologyUniversity of MiamiAvslutadSenil Purpura | Batemans PurpuraFörenta staterna